Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.60
Bid: 38.60
Ask: 38.70
Change: 0.40 (1.05%)
Spread: 0.10 (0.259%)
Open: 38.30
High: 40.70
Low: 37.70
Prev. Close: 38.20
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

10 Jun 2019 07:00

RNS Number : 5999B
Accrol Group Holdings PLC
10 June 2019
 

 

 

The information contained within this announcement is deemed by the Group to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

10 June 2019

Accrol Group Holdings plc

("Accrol" or the "Group")

 

TRADING UPDATE AND NOTICE OF RESULTS

 

The Board of Accrol is pleased to announce the following trading update ahead of its results for the full year ended 30 April 2019 ("FY19"), which will be announced on 3 September 2019.

 

Following the conclusion of the restructuring, the Group performed well in Q4 and in line with the management's strategic turnaround objectives, achieving and maintaining acceptable levels of monthly profitability on an Adjusted EBITDA level.

 

Total revenues in FY19 were c.£119 million, broadly unchanged on a like for like basis against the prior year, as the Group exited a number of low margin contracts. Sales in the Group's core toilet roll product, however, increased by c.12% year on year to c.£85 million from £76 million in FY18. Adjusted EBITDA was c.£1 million, representing a c.£7 million improvement on the prior year despite the substantial impact of FX and material cost headwinds which increased by an estimated c.£10 million. Adjusted loss before tax is expected to be in the range of £2.5 million to £3.0 million. Exceptional costs, primarily associated with the turnaround process, are expected to be in the range of £7.5 million to £8.0 million. Net debt was reduced faster than anticipated, finishing the year at c.£27.1 million, c.£2.5 million lower than the previously anticipated level of c.£29.6 million, ensuring that the Group comfortably fulfilled on its banking commitments.

 

Dan Wright, Chairman of Accrol, said:

 

"I am very pleased to report that we finished FY19 in a much stronger position, following the conclusion of a transformational restructuring, and that the new financial year has started well. The Group is now enjoying the full benefits of the structural cost savings achieved in FY19, achieving an acceptable level of margin for a business of its type. Our management team is confident of delivering further profitable revenue growth and creating new exciting opportunities for the Group. I look forward to reporting further details of our progress when we announce the Final Results in September."

 

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Dan Wright, Executive Chairman

Tel: +44 (0) 1254 278 844

Gareth Jenkins, Chief Executive Officer

 

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Andrew Jones

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

Belvedere Communications Limited

 

Cat Valentine (cvalentine@belvederepr.com)

Tel: +44 (0) 7715 769 078

Keeley Clarke (kclarke@belvederepr.com)

Tel: +44 (0) 7967 816 525

Llew Angus (langus@belvederpr.com)

Tel: +44 (0)7407 023 147

 

Notes to Editors

 

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. Accrol operates from three sites:

 

·

A manufacturing, storage and distribution facility in Blackburn;

·

A facial tissue plant, also in Blackburn; and

·

A manufacturing, storage and distribution facility in Leyland.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLFFIIRRIAIIA
Date   Source Headline
21st May 20202:25 pmRNSTR-1
6th May 20207:00 amRNSTrading Update
25th Mar 202010:19 amRNSTR-1
23rd Mar 202011:35 amRNSTR-1
17th Mar 20207:00 amRNSAppointment of Joint Broker
4th Mar 20207:00 amRNSTR-1
3rd Mar 20209:41 amRNSTR-1
29th Jan 20207:00 amRNSDirector's Dealing
21st Jan 20209:13 amRNSTR-1
20th Jan 20207:00 amRNSRegulatory investigation closed
15th Jan 20207:00 amRNSTR-1
14th Jan 20207:00 amRNSTR-1
7th Jan 20207:00 amRNSHalf Year Results
16th Dec 20197:00 amRNSTR-1
13th Nov 201912:11 pmRNSTR-1
22nd Oct 201911:30 amRNSResult of AGM
17th Oct 20198:00 amRNSVesting of FY2019 Share Option Awards
26th Sep 20198:30 amRNSNotice of AGM
6th Sep 201911:52 amRNSTR-1
3rd Sep 20197:00 amRNSAudited Final Results
10th Jun 20197:00 amRNSTrading Update and Notice of Results
25th Apr 20194:32 pmRNSDirector/PDMR Shareholding
10th Apr 20197:00 amRNSSenior Management Change
27th Mar 201910:20 amRNSRegulatory Investigation Update
11th Feb 20194:35 pmRNSDirector/PDMR Shareholding
6th Feb 20193:03 pmRNSHolding(s) in Company
22nd Jan 20195:15 pmRNSDirector's Dealing
22nd Jan 20199:05 amRNSSecond Price Monitoring Extn
22nd Jan 20199:00 amRNSPrice Monitoring Extension
22nd Jan 20197:01 amRNSHalf Year Results
22nd Jan 20197:00 amRNSBoard Change and Senior Management Appointment
21st Jan 20192:20 pmRNSRegulatory Investigation
10th Jan 20191:35 pmRNSHolding(s) in Company
8th Jan 201911:05 amRNSSecond Price Monitoring Extn
8th Jan 201911:00 amRNSPrice Monitoring Extension
8th Jan 20197:00 amRNSTrading Update
23rd Nov 20187:00 amRNSAccrol Group to present at Mello London
30th Oct 201811:37 amRNSResult of AGM
30th Oct 20187:00 amRNSPDMR Dealings
29th Oct 201811:24 amRNSBoard and Board Committee Changes
10th Oct 20187:00 amRNSAppointment of Non Executive Director
28th Sep 20187:00 amRNSAudited Final Results and Notice of AGM
26th Sep 20187:00 amRNSUnaudited Final Results 2018 and Banking Update
28th Aug 20187:00 amRNSBoard and Senior Management Changes
11th Jul 20187:00 amRNSNotice of Final Results
11th Jul 20187:00 amRNSDirectorate Change
9th Jul 20184:04 pmRNSHolding(s) in Company
18th Jun 20184:39 pmRNSDirector's Dealings
18th Jun 20187:00 amRNSHolding(s) in Company
12th Jun 20183:47 pmRNSDirectors' Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.